Clinical Trials Sponsored by Comprehensive Cancer Centre The Netherlands

Total 7183 results

Comprehensive Cancer Centre The Netherlands

Recruiting

High-Risk prostatE Cancer radiatiOn Versus surgERy (RECOVER)

Prostate Cancer | Prostate Adenocarcinoma

Netherlands
Memorial Sloan Kettering Cancer Center
Comprehensive Cancer Centre The Netherlands

Recruiting

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Cancer | Dermatologic Conditions

United States
UMC Utrecht
Comprehensive Cancer Centre The Netherlands

Unknown

EMR Versus ESD for Resection of Large Distal Non-pedunculated Colorectal Adenomas (MATILDA)

Colorectal Neoplasms

Netherlands
Maastricht Radiation Oncology
Comprehensive Cancer Centre The Netherlands

Withdrawn

Time Trends in Waiting Times of NSCLC Patients.

Non-Small Cell Lung Cancer

Netherlands
Leiden University Medical Center
Comprehensive Cancer Centre The Netherlands; Dutch Cancer Society

Active, not recruiting

PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer (PORTEC-4a)

Endometrial Cancer Stage I | Endometrial Cancer Stage II

Netherlands, Germany, Belgium, France, Austria, Czechia, Ireland, Switzerland
Comprehensive Cancer Centre The Netherlands
Tilburg University; Netherlands Organisation for Scientific Research

Recruiting

Distress In CErvical Cancer Patients and Partners (DICE)

Quality of Life | Cervical Cancer | Psychological Distress | Survivorship | Psychologic Stress

Netherlands
Comprehensive Cancer Centre The Netherlands
Maastricht University Medical Center; Leiden University Medical Center; Dutch...

Completed

ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More? (ENSURE)

Endometrial Cancer

Netherlands
Jeroen Bosch Ziekenhuis
Borstkanker Onderzoek Groep; Comprehensive Cancer Centre The Netherlands

Terminated

Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer (SUBMIT)

Metastatic Breast Cancer

Netherlands
The Netherlands Cancer Institute
Erasmus Medical Center

Recruiting

Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT) (PUMP-IT)

Colorectal Neoplasms

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Comprehensive Cancer Centre The Netherlands

Not yet recruiting

Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy (PrimerX)

Renal Cell Carcinoma
Daniëlle van de Graaf
Comprehensive Cancer Centre The Netherlands; Dutch Cancer Society

Recruiting

Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN (QLIPP-CIPN)

Chemotherapy-induced Peripheral Neuropathy | Cancer Survivors

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer (DECIDE)

NSCLC
The Netherlands Cancer Institute

Recruiting

A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL (DESTINATION)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients (Chemosense)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC (VULCANIZE-II)

Squamous Cell Carcinoma of the Vulva | Locally Advanced Vulvar Carcinoma

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery (SPACU-lab)

Pain, Postoperative | Stress, Psychological | Stress, Physiological | Surgical Injury
The Netherlands Cancer Institute

Recruiting

FMT to Convert Response to Immunotherapy

Melanoma Stage IV | Melanoma Stage III

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Blood Sampling of Healthy Volunteers for Immunological Research

Healthy Volunteers

Netherlands
The Netherlands Cancer Institute

Enrolling by invitation

The Food-effect on Alectinib Pharmacokinetics

NSCLC

Netherlands
The Netherlands Cancer Institute

Completed

Navigated Abdominal Lymph Node Dissections (N16LND)

Lymph Node Metastasis | Image-guide Surgery

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (neo-TN)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Health-related Quality of Life and Late Effects Among SURVivors of Cancer in Adolescence and Young Adulthood: The SURVAYA Study

Quality of Life | Cancer | Lifestyle | Survivorship | Late Effect

Netherlands
The Netherlands Cancer Institute

Completed

Dose-Effect Relation of Salivary Gland Irradiation

HNSCC

Netherlands
The Netherlands Cancer Institute

Terminated

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Preoperative Breast Irradiation (PROBI)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (N12HYB)

Inoperable Locally Advanced Non Small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT) (SUSPECT)

Head and Neck Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

Melanoma | Skin Neoplasms

Netherlands
The Netherlands Cancer Institute

Withdrawn

Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC (HYPOLAN)

Non-Small Cell Lung Cancer
The Netherlands Cancer Institute

Completed

Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer (PAPBI)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Study With Improved Solubility Pazopanib

Pharmacokinetics of Pazopanib

Netherlands
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
University Medical Center Groningen
The Netherlands Cancer Institute

Completed

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

Breast Cancer Female

Netherlands
The Netherlands Cancer Institute
Leiden University Medical Center

Unknown

Improving the Safety of Fluoropyrimidine-based Chemotherapy (Alpe2U)

Neoplasms

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE)

Melanoma

Netherlands
The Netherlands Cancer Institute

Recruiting

Image-guided Navigation During Robotic Sentinel Node Removal (N21LND)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Improved Implant for Reconstruction Purposes After Mandibular Resection (RifRam)

Head and Neck Cancer | Oral Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prospective Observational COMPRAYA Cohort Study (COMPRAYA)

Cancer | Fertility Issues | Genetic Disease | Lifestyle | Survivorship | Distress, Emotional | Second Cancer

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
The Netherlands Cancer Institute

Terminated

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (DOP)

Prostatic Neoplasms

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Multicentric Randomised Trial for Resectable Gastric Cancer (CRITICS-II)

Gastric Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (Subito)

Breast Cancer

Netherlands, France
The Netherlands Cancer Institute

Completed

Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery

Abdominal Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY)

Myxoid Liposarcoma of Soft Tissue

Netherlands, United Kingdom, Norway, United States, Denmark
The Netherlands Cancer Institute

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
The Netherlands Cancer Institute

Terminated

Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors

Brain Tumor

Netherlands
The Netherlands Cancer Institute

Completed

Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands

Clinical Trials Sponsored by Comprehensive Cancer Centre The Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations